Skip to content

Cardiorespiratory Response During Whole Body Vibration Training in Patients With Chronic Lung Disease

Cardiorespiratory Response During Whole Body Vibration Training in Patients With Chronic Obstructive Pulmonary Disease (COPD) or Interstitial Lung Disease (ILD)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01898143
Enrollment
10
Registered
2013-07-12
Start date
2013-06-30
Completion date
2015-05-31
Last updated
2016-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Lung Disease (n=10), Interstitial Lung Disease (n=10)

Keywords

Whole body vibration, cardiorespiratory response

Brief summary

Whole body vibration training seems to be a useful adjunct in exercise training in patients with severe COPD. The basic principle relies on reflectory muscle contractions caused by a vibration stimulus. Until now the impact of whole body vibration training on cardiopulmonary parameters remained unknown. Therefore aim of this study is to investigate cardiopulmonary parameters during whole body vibration training in patients with chronic lung disease.

Interventions

OTHERWhole body vibration

Sponsors

Schön Klinik Berchtesgadener Land
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* COPD stage III or IV according to the Global Initiative for chronic obstructive lung disease \[GOLD\]) * Interstitial Lung disease (forced vital capacity (FVC) \< 70% pred., diffusion capacity of lung for carbon monoxide (DLCO) 30-70% pred.)

Exclusion criteria

* Oxygen therapy during exercise required * Severe exacerbation of lung disease, with necessity of change in medication or persistent symptoms \> 3days * activated arthrosis /arthropathy/ rheumatoid Arthritis/ acute discopathy * acute thrombosis * acute musculoskeletal inflammation * Epilepsy * Gallstones

Design outcomes

Primary

MeasureTime frameDescription
peak oxygen consumption (VO2 peak)during 1 exercise sessionsubjects perform several short bouts (1 to 3 minutes duration) of squatting exercise with or without whole body vibration. The peak values of each single part is used for comparison.

Secondary

MeasureTime frameDescription
minute ventilation (VE)during 1 exercise sessionsubjects perform several short bouts (1 to 3 minutes duration) of squatting exercise with or without whole body vibration. The peak values of each single part is used for comparison.
perceived exertion for dyspnea and leg fatigue (Borg-scale)during 1 exercise sessionsubjects perform several short bouts (1 to 3 minutes duration) of squatting exercise with or without whole body vibration. The peak values of each single part is used for comparison.
heart rate (HR)during 1 exercise sessionsubjects perform several short bouts (1 to 3 minutes duration) of squatting exercise with or without whole body vibration. The peak values of each single part is used for comparison.
breathing frequency (BF)during 1 exercise sessionsubjects perform several short bouts (1 to 3 minutes duration) of squatting exercise with or without whole body vibration. The peak values of each single part is used for comparison.
peak carbon-dioxide consumption (VCO2 peak)during 1 exercise sessionsubjects perform several short bouts (1 to 3 minutes duration) of squatting exercise with or without whole body vibration. The peak values of each single part is used for comparison.
Alveolar-arterial oxygen difference (AaDO2)during 1 exercise sessionsubjects perform several short bouts (1 to 3 minutes duration) of squatting exercise with or without whole body vibration. The peak values of each single part is used for comparison.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026